1.07
price up icon0.00%   0.00
after-market 시간 외 거래: 1.08 0.01 +0.93%
loading
전일 마감가:
$1.07
열려 있는:
$1.0505
하루 거래량:
96,264
Relative Volume:
0.15
시가총액:
$43.14M
수익:
-
순이익/손실:
$-66.88M
주가수익비율:
-0.5944
EPS:
-1.8
순현금흐름:
$-62.91M
1주 성능:
+0.00%
1개월 성능:
+7.86%
6개월 성능:
+13.37%
1년 성능:
+32.92%
1일 변동 폭
Value
$1.05
$1.08
1주일 범위
Value
$1.01
$1.08
52주 변동 폭
Value
$0.63
$1.76

아킬레스 테라퓨틱스 Stock (ACHL) Company Profile

Name
명칭
Achilles Therapeutics Plc Adr
Name
전화
-
Name
주소
-
Name
직원
215
Name
트위터
Name
다음 수익 날짜
2024-12-11
Name
최신 SEC 제출 서류
Name
ACHL's Discussions on Twitter

ACHL을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
ACHL 1.07 43.14M 0 -66.88M -62.91M -1.80
VRTX 450.37 115.43B 10.63B -479.80M -1.35B 13.33
REGN 744.50 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.74 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.23 24.89B 3.30B -501.07M 1.03B 11.54

아킬레스 테라퓨틱스 Stock (ACHL) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-04-26 개시 BofA Securities Buy
2021-04-26 개시 Chardan Capital Markets Buy
2021-04-26 개시 JP Morgan Underweight
2021-04-26 개시 Oppenheimer Outperform
2021-04-26 개시 Piper Sandler Overweight

아킬레스 테라퓨틱스 주식(ACHL)의 최신 뉴스

pulisher
Nov 19, 2024

Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market - GlobeNewswire Inc.

Nov 19, 2024
pulisher
Oct 16, 2024

80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight - 新浪香港

Oct 16, 2024
pulisher
Sep 23, 2024

ACHL’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Sep 23, 2024
pulisher
Sep 23, 2024

Check Out Achilles Therapeutics Plc ADR (ACHL)’s Trade Data Rather Than the Analysts’ Views - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

Is Achilles Therapeutics (ACHL) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Sep 23, 2024
pulisher
Sep 20, 2024

why Achilles Therapeutics Plc ADR [ACHL] is a Good Choice for Investors After New Price Target of $1.25 - The DBT News

Sep 20, 2024
pulisher
Sep 20, 2024

What Analysts Were Expecting After PowerFleet Inc (NASDAQ: AIOT) rose 2.40% - Stocks Register

Sep 20, 2024
pulisher
Sep 20, 2024

Achilles Thera shifts focus to new cancer treatment avenues - The Pharma Letter

Sep 20, 2024
pulisher
Sep 19, 2024

Achilles Therapeutics ends TIL-based cancer therapy trials - Investing.com

Sep 19, 2024
pulisher
Sep 19, 2024

You Should Read This Analysis Before Investing in Achilles Therapeutics Plc ADR (NASDAQ:ACHL) - US Post News

Sep 19, 2024
pulisher
Sep 19, 2024

Achilles stock climbs on strategic focus (NASDAQ:ACHL) - Seeking Alpha

Sep 19, 2024
pulisher
Sep 19, 2024

Achilles Therapeutics Announces Strategic Update - Yahoo Finance

Sep 19, 2024
pulisher
Aug 14, 2024

Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates - GlobeNewswire

Aug 14, 2024
pulisher
Jun 27, 2024

Immunovant (IMVT) Up More Than 20% in Past 3 Months: Here's Why - Yahoo New Zealand News

Jun 27, 2024
pulisher
Jun 24, 2024

Kodiak Sciences (KOD) Rises 60% in Past 3 Months: Here's Why - Yahoo Sport Australia

Jun 24, 2024
pulisher
Jun 19, 2024

Achilles Therapeutics Plc ADR (ACHL) Clearly Signals Buy-Into the Stock: Don't ignore the signals – Sete News - SETE News

Jun 19, 2024
pulisher
Jun 04, 2024

Amgen's (AMGN) Lumakras Meets Goal in New Lung Cancer Study - Yahoo Lifestyle UK

Jun 04, 2024
pulisher
May 25, 2024

Blueprint Medicines' (BPMC) Ayvakit Meets Goal in PIONEER Study - Yahoo Movies UK

May 25, 2024
pulisher
May 24, 2024

Waters (WAT) Walk-Up Solutions Boost Bioprocess Development - Yahoo Lifestyle UK

May 24, 2024
pulisher
May 22, 2024

Achilles Therapeutics and Arcturus team up for cancer vaccine By Investing.com - Investing.com

May 22, 2024
pulisher
May 22, 2024

Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation ... - GlobeNewswire

May 22, 2024
pulisher
May 22, 2024

Achilles Therapeutics Announces Research Collaboration with - GlobeNewswire

May 22, 2024
pulisher
May 17, 2024

Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement - GlobeNewswire

May 17, 2024
pulisher
May 17, 2024

Achilles Therapeutics faces Nasdaq delisting over share price - Investing.com

May 17, 2024
pulisher
May 09, 2024

Achilles Therapeutics Plc ADR's Shares Reel: -0.12% Quarterly Revenue Decline Amid 37.75M Market Cap – Invest ... - The InvestChronicle

May 09, 2024
pulisher
May 08, 2024

Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire

May 08, 2024
pulisher
Apr 04, 2024

Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC ... - GlobeNewswire

Apr 04, 2024
pulisher
Feb 09, 2024

Is ImmunoGen (IMGN) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Feb 09, 2024
pulisher
Feb 05, 2024

Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference - GlobeNewswire

Feb 05, 2024
pulisher
Jan 24, 2024

Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jan 24, 2024
pulisher
Nov 13, 2023

Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights - GlobeNewswire

Nov 13, 2023
pulisher
Sep 20, 2023

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation - Quantisnow

Sep 20, 2023
pulisher
Nov 01, 2022

What Makes Achilles Therapeutics PLC Sponsored ADR (ACHL) a New Buy Stock - Yahoo Finance

Nov 01, 2022
pulisher
Sep 09, 2022

Apellis (APLS) Up More Than 60% in Past 3 Months: Here's Why - Nasdaq

Sep 09, 2022
pulisher
Sep 05, 2022

Immuneering (IMRX) Files IND for Cancer Candidate IMM-1-104 - Yahoo Finance

Sep 05, 2022
pulisher
Aug 22, 2022

Axsome (AXSM) Soars on FDA Nod for Depression Drug, Auvelity - Yahoo Finance Australia

Aug 22, 2022
pulisher
Aug 16, 2022

Horizon (HZNP) Inks Collaboration Deal with Q32 Bio for ADX-914 - Yahoo New Zealand News

Aug 16, 2022
pulisher
Jun 30, 2022

Achilles Therapeutics Appoints James Taylor as Chief Business Officer and Cassian Yee, MD to Scientific Advisory Board - GlobeNewswire

Jun 30, 2022
pulisher
Dec 24, 2021

Achilles Therapeutics PlcADR Shares Close the Day 10.1% HigherDaily Wrap - Nasdaq

Dec 24, 2021
pulisher
Mar 30, 2021

Achilles Therapeutics Announces Pricing of Initial Public Offering - GlobeNewswire

Mar 30, 2021
pulisher
Jul 27, 2011

ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN

Jul 27, 2011

아킬레스 테라퓨틱스 (ACHL) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.56%
$367.36
price up icon 0.77%
$194.56
price up icon 0.07%
$108.23
price up icon 5.98%
자본화:     |  볼륨(24시간):